{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.1444.5.242",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "American Society of Clinical Oncology Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-10-09"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2022-09-10"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.242",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.1444.5.242"
    }
  ],
  "version" : "20220910",
  "name" : "HighEmeticRiskIntravenousAntineoplasticAgent",
  "title" : "High Emetic Risk Intravenous Antineoplastic Agent",
  "status" : "active",
  "experimental" : false,
  "date" : "2022-09-10T01:02:30-04:00",
  "publisher" : "American Society of Clinical Oncology Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of high emetic risk intravenous antineoplastic agent.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a high emetic risk intravenous antineoplastic medication; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
  "compose" : {
    "include" : [
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.222"
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:571e219b-403d-497a-b45e-21d11b896a68",
    "timestamp" : "2024-11-09T00:54:13-05:00",
    "total" : 8,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "1731338",
        "display" : "dacarbazine 200 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "1731340",
        "display" : "dacarbazine 100 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "1736854",
        "display" : "cisplatin 50 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "239180",
        "display" : "streptozocin 1000 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "2605054",
        "display" : "carmustine 300 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "2605056",
        "display" : "carmustine 50 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "309012",
        "display" : "carmustine 100 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "10072024",
        "code" : "309311",
        "display" : "cisplatin 1 MG/ML Injectable Solution"
      }
    ]
  }
}
